Yvonne Commodore-Mensah, PhD, MHS, RN Profile
Yvonne Commodore-Mensah, PhD, MHS, RN

@ycommodore

Followers
3K
Following
5K
Media
439
Statuses
3K

Professor,Cardiovascular Nurse Epidemiologist, President @GDNANursing Editor @jadvnursing.#immigranthealth #healthequity 🇬🇭🇺🇸

Baltimore, MD
Joined September 2013
Don't wanna be here? Send us removal request.
@AnastasiaSMihai
Dr Anastasia Mihailidou FAHA FCSANZ FESC
1 month
Congratulations & due recognition @dramitkhera 👏👏 Receiving @American_Heart @AHAScience #AHA25 Chairman’s Award🙌 A joy & honour to serve as one of #AHA Lead Science Communicators & experienced your #Enthusiasm #Energy #Positivity & #Compassion🙏 @drstaceyrosen @NancyatHeart
2
8
34
@ChiadiNdumele
Chiadi Ndumele
1 month
Don't miss fantastic Core Preventive Cardiology programming at #AHA2025 today! 8 AM: Redifining Obesity Definitions/Approaches w/ 1st author of Lancet Obesity Commission, modeling of weight mgmt discussion & patient panel. 3:30 PM: Core Competencies in Prevention. See you there!!
1
7
22
@Sfugarmd
Setri Fugar MD
1 month
Proud to share our DAMSUN-HF study, published in Circulation! We demonstrated that an AI-enabled stethoscope can accurately diagnose heart failure in LMIC, offering a scalable tool for global cardiovascular care. 🔗 https://t.co/eeYjTUmXLf #EkoHealth #MedTwitter #CirculationAHA
1
3
11
@NancyatHeart
nancyatheart
1 month
Yesterday we kicked off @American_Heart’s Scientific Sessions 2025 by connecting with our incredible early career professionals, hearing the powerful stories of patients, and beginning to unveil the exciting late-breaking science that is the hallmark of our international
0
4
25
@AHAScience
AHA Science
1 month
PREVENT equation 🤝 cardiovascular kidney metabolic health Learn more about CKM and PREVENT at #AHA25 🎥 @HeartDocSadiya
0
4
32
@ycommodore
Yvonne Commodore-Mensah, PhD, MHS, RN
1 month
Does patient provider concordance matter? Maybe. We need more robust study designs. We also need to diversify the health workforce and improve communication. @emilyswlau #AHA25
0
0
6
@emilyswlau
Emily Lau, MD, MPH
1 month
Celebrating Women in Cardiology at AHA 2025 ❤️ An inspiring afternoon at @AHAScience #WIC Luncheon, where leaders, mentors, and future changemakers came together to celebrate excellence and equity in our field.
1
12
68
@ycommodore
Yvonne Commodore-Mensah, PhD, MHS, RN
1 month
Physical activity improves heart♥️ health but the existing guidelines are not sex specific. @DrMarthaGulati makes a strong case for sex differences in response to physical activity and fitness at #AHA25.
0
2
6
@AbenaKAgyekum
Abena K. Agyekum, MD
1 month
@ycommodore does an excellent job breaking down how women and minority groups are underrepresented in clinical trials. She emphasizes: 🫀Building intercommunity relationships 🫀Offer flexible scheduling 🫀Increased research funding #AHA25 #cardiotwitter
0
1
4
@ycommodore
Yvonne Commodore-Mensah, PhD, MHS, RN
1 month
Dr. @modeldoc made a compelling case for assessing and addressing social determinants of health in #HeartFailure at #AHA25. @GradyHealth @EmoryMedicine
0
5
9
@ycommodore
Yvonne Commodore-Mensah, PhD, MHS, RN
1 month
Fantastic presentation by @YulingChen20, postdoc at @JHUNursing, on the association between Shared Decision Making and Self reported health among adults with cardiometabolic disease. #AHA25
1
2
14
@GarimaVSharmaMD
Garima Sharma M.D
1 month
Fantastic day @AHAScience #AHA2025 for these amazing scientists and mentees from @ISHVnews 7 original science presentations from our lab! @coconnormd @JSpitz_MD @BrazileTiffany @fmetlock @DrDastmalchi
1
12
35
@DrMarthaGulati
Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦
1 month
First in Class triple agonist targeting FGF21 triple glucagonreceptor, GLP1R TG, Lipids & liver fat: Phase 2, 12 week trial ♥️ 1/2 women enrolled 📍Primary endpoint: change in TG: reduced in all groups 📍⤵️ Non HDL and TChol 📍⤵️ Liver fat content: <5% 📍⤴️ insulin sensitivity 📍
2
23
108
@GarimaVSharmaMD
Garima Sharma M.D
1 month
Late breaking #LBTC session 1 with focus on novel therapies in severe hypertriglyceridemia . Core 1TIMI72a and Core 2 TIMI 72b showing incredible promise for Olezarsen in SHTG reduction and prevention of pancreatitis ARR 32% @AHAScience #AHA2025 .
0
8
33
@ycommodore
Yvonne Commodore-Mensah, PhD, MHS, RN
1 month
2.🔬 Breaking data from #AHA25: @marstonMD presented CORE-TIMI 72A & 72B trials on olezarsen (50mg & 80mg), demonstrating: 📉 65% reduction in triglycerides 📉 Decreased ApoC-III & non-HDL-C and 📉 85% lower risk of acute pancreatitis Major advance for severe lipid management!
0
0
1
@ycommodore
Yvonne Commodore-Mensah, PhD, MHS, RN
1 month
1.Dr. Jiaping Li presents trial showing that treatment with DR10624, a GLP-1 Tri-agonist reduced triglycerides, atherogenjc lipids and liver fats in a 12 week phase 2 clinical trial among participants with severe hyper triglyceridemia.
1
0
0
@ycommodore
Yvonne Commodore-Mensah, PhD, MHS, RN
1 month
The 1st Late Breaking Abstract session is moderated by @ChiadiNdumele, @drstaceyrosen, Eugenia Gianos and Karol Watson. #AHA25
1
0
5
@JoChikweMD
Jo Chikwe
1 month
>10,000 abstract submissions >5000 presentations > 80 simultaneous publications > 20 pivotal trials 1 Nobel Laureate #aha2025
4
33
128
@AHAScience
AHA Science
1 month
Take a behind-the-scenes look at the heart of Scientific Sessions #AHA25. Science Communicator @MoradiShayan joins our Committee Chair @JoChikweMD and Vice Chair @bnallamo for a walk-through of the energy and preparation behind the meeting. Not attending in person? You can still
0
10
31
@AHAScience
AHA Science
1 month
Make sure the Food is Medicine Pavilion is on your schedule for #AHA25. Each day is packed with research updates, panel discussions and more, brought to you by the Health Care by Food Initiative. Join us Friday, Saturday and Sunday. @chrisreyes84 @ycommodore @bunmiogungbe09
0
5
14